Phases of Wound Healing
Introduction
Wound healing is a remarkably orchestrated biological process that restores tissue integrity following injury. This ancient survival mechanism involves the precise coordination of multiple cell types, molecular signals, and matrix components in a temporal sequence that, when successful, closes wounds and restores function.
Understanding wound healing is essential for dermatologists because disruptions in this process underlie chronic wounds, keloids, hypertrophic scars, and poor surgical outcomes. Moreover, many skin diseases and therapeutic interventions affect wound healing, making this knowledge clinically actionable.
The wound healing cascade is classically divided into four overlapping phases: hemostasis, inflammation, proliferation, and remodeling. Each phase builds upon the previous one, with complex feedback mechanisms ensuring orderly progression.
Overview of Wound Healing Phases
Loading diagram...
Phase Overview
| Phase | Timing | Key Cells | Key Events | Key Mediators |
|---|---|---|---|---|
| Hemostasis | 0-1 hours | Platelets | Clot formation, vasoconstriction | Thrombin, fibrin, TXA₂ |
| Inflammation | 1-7 days | Neutrophils, macrophages | Debridement, pathogen defense | IL-1, TNF-α, IL-6, TGF-β |
| Proliferation | 4-21 days | Keratinocytes, fibroblasts, endothelial cells | Re-epithelialization, granulation tissue, angiogenesis | VEGF, PDGF, FGF, EGF |
| Remodeling | 21 days-2 years | Fibroblasts, myofibroblasts | Collagen maturation, scar formation | TGF-β, MMPs, TIMPs |
Phase I: Hemostasis (Minutes to Hours)
Immediate Response to Injury
The moment skin is injured, a cascade of events is triggered to stop bleeding and create a provisional matrix for subsequent healing.
Loading diagram...
Platelet-Derived Growth Factors
Platelet alpha granules release critical growth factors that orchestrate subsequent healing phases.
| Growth Factor | Source | Target Cells | Function |
|---|---|---|---|
| PDGF | Platelets, macrophages | Fibroblasts, SMCs | Chemotaxis, proliferation |
| TGF-β | Platelets, macrophages | Multiple | Matrix synthesis, fibrosis |
| EGF | Platelets, macrophages | Keratinocytes | Re-epithelialization |
| VEGF | Platelets | Endothelial cells | Angiogenesis |
| FGF | Platelets | Multiple | Proliferation, angiogenesis |
Provisional Matrix
The fibrin clot serves as a provisional matrix—a temporary scaffold that:
- Provides structural support
- Traps growth factors
- Creates a chemotactic gradient for migrating cells
- Protects the wound from pathogens
Phase II: Inflammation (Days 1-7)
Purpose of Inflammation
The inflammatory phase serves critical functions:
- Debridement: Removal of dead tissue and debris
- Pathogen defense: Bacterial killing
- Signal amplification: Recruitment of more cells
- Transition signaling: Preparing for proliferative phase
Cellular Choreography
Loading diagram...
Neutrophil Functions
| Function | Mechanism | Products |
|---|---|---|
| Phagocytosis | Engulfment of bacteria/debris | — |
| Oxidative burst | NADPH oxidase | Superoxide, H₂O₂, HOCl |
| Degranulation | Enzyme release | Elastase, cathepsins, MMPs |
| NETs formation | DNA extrusion | Neutrophil extracellular traps |
| Cytokine release | Signaling | IL-1β, IL-6, TNF-α |
Macrophage Polarization
Macrophages are the "master regulators" of wound healing, transitioning from pro-inflammatory (M1) to pro-healing (M2) phenotypes.
Loading diagram...
| Feature | M1 Macrophage | M2 Macrophage |
|---|---|---|
| Timing | Days 1-3 | Days 3-7+ |
| Inducers | IFN-γ, LPS, TNF-α | IL-4, IL-10, IL-13, TGF-β |
| Function | Pro-inflammatory | Pro-healing |
| Products | iNOS, ROS, IL-1, TNF | Arginase, TGF-β, VEGF |
| Metabolism | Glycolytic | Oxidative phosphorylation |
| Wound role | Debridement | Resolution, repair |
Resolution of Inflammation
The transition from inflammation to proliferation requires active resolution:
- Neutrophil apoptosis: Programmed death (not necrosis)
- Efferocytosis: Macrophage engulfment of apoptotic neutrophils
- Pro-resolving mediators: Lipoxins, resolvins, protectins
- M1→M2 switch: Anti-inflammatory reprogramming
Clinical Pearl: Impaired M1→M2 transition is a hallmark of chronic wounds (diabetic ulcers), leading to persistent inflammation and failed healing.
Phase III: Proliferation (Days 4-21)
Overview of Proliferative Events
The proliferation phase involves three concurrent processes:
- Re-epithelialization: Closure of epithelial gap
- Granulation tissue formation: New connective tissue
- Angiogenesis: New blood vessel formation
Loading diagram...
Re-epithelialization
Keratinocytes at the wound edge undergo a phenotypic switch to migratory cells.
| Event | Mechanism | Key Molecules |
|---|---|---|
| Activation | Phenotypic change | EGF, KGF, HGF |
| Migration | Crawling/leapfrogging | Integrins (α5β1, αvβ6), MMPs |
| Proliferation | Mitosis behind leading edge | EGF, IGF-1 |
| Differentiation | Stratification resumes | Calcium gradient |
| Contact inhibition | Stop signal | Cadherin reconnection |
Migration Pattern: Epithelial Tongue
Loading diagram...
Granulation Tissue
Granulation tissue is the provisional connective tissue that fills the wound—so named for its granular, red appearance clinically.
| Component | Source | Function |
|---|---|---|
| Fibroblasts | Dermis, bone marrow | Matrix production |
| Capillaries | Angiogenesis | Oxygen/nutrient delivery |
| Collagen III | Fibroblasts | Provisional matrix |
| Fibronectin | Fibroblasts, plasma | Cell migration scaffold |
| Proteoglycans | Fibroblasts | Hydration, signaling |
| Inflammatory cells | Circulation | Ongoing signaling |
Angiogenesis
New blood vessel formation is essential to supply the metabolically active healing tissue.
Loading diagram...
Key Growth Factors in Proliferation
Loading diagram...
Phase IV: Remodeling (Day 21 to 2 Years)
Overview
The remodeling (maturation) phase is the longest phase, during which the initial wound matrix is reorganized to approach (but never reach) normal tissue.
Loading diagram...
Collagen Remodeling
| Feature | Early (Type III) | Late (Type I) |
|---|---|---|
| Timing | Days 3-21 | Weeks 3 to years |
| Fiber diameter | Small | Large, thick bundles |
| Organization | Random | Parallel to stress lines |
| Cross-linking | Minimal | Extensive (lysyl oxidase) |
| Tensile strength | 15-20% normal | 70-80% normal (max) |
MMP/TIMP Balance
The remodeling phase requires a delicate balance between matrix metalloproteinases (degradation) and tissue inhibitors of metalloproteinases (preservation).
| Factor | Function | Imbalance Effect |
|---|---|---|
| MMPs | Collagen degradation | ↑ = Chronic wound |
| TIMPs | MMP inhibition | ↓ = Excessive degradation |
| TGF-β | ↑ Collagen synthesis, ↓ MMPs | ↑ = Excessive scarring |
Scar Formation
Normal wound healing results in a scar—tissue that differs from the original:
| Feature | Normal Skin | Scar Tissue |
|---|---|---|
| Collagen organization | Basket-weave pattern | Parallel bundles |
| Tensile strength | 100% | 70-80% maximum |
| Appendages | Present (hair, glands) | Absent |
| Elasticity | Normal | Reduced |
| Color | Normal | Initially red, then pale |
Wound Healing Types
Primary vs. Secondary Intention
Loading diagram...
Wound Contraction
In secondary intention healing, wound contraction significantly reduces wound size:
| Mechanism | Mediator | Contribution |
|---|---|---|
| Myofibroblast contraction | α-SMA | Primary mechanism |
| Fibroblast traction | Collagen gel compaction | Early contribution |
| Rate | ~0.6-0.75 mm/day | Variable by site |
| Maximum | 40-80% size reduction | Depends on wound shape |
Factors Affecting Wound Healing
Local Factors
Loading diagram...
Systemic Factors
| Factor | Effect on Healing | Mechanism |
|---|---|---|
| Diabetes | ↓↓ Impaired | Hyperglycemia, neuropathy, vasculopathy |
| Advanced age | ↓ Slower | Decreased cell function, thin skin |
| Malnutrition | ↓↓ Impaired | Protein, vitamin C, zinc deficiency |
| Immunosuppression | ↓ Impaired | Reduced inflammatory phase |
| Corticosteroids | ↓ Impaired | ↓ Inflammation, ↓ collagen synthesis |
| Smoking | ↓ Impaired | Vasoconstriction, ↓ oxygen |
| Obesity | ↓ Impaired | ↓ Perfusion, ↑ tension |
| Peripheral vascular disease | ↓↓ Impaired | ↓ Perfusion, ↓ oxygen |
Chronic Wound Environment
Loading diagram...
Summary: Wound Healing at a Glance
Loading diagram...
Key Clinical Pearls
| Topic | Pearl |
|---|---|
| Hemostasis | Platelet α-granules release growth factors that drive subsequent healing |
| Inflammation | M1→M2 macrophage transition is critical; failure = chronic wound |
| Proliferation | Granulation tissue is red and granular; pale tissue suggests ischemia |
| Re-epithelialization | Keratinocytes migrate over provisional matrix, not exposed dermis |
| Remodeling | Scar never exceeds 80% normal tensile strength |
| Moist healing | Moist wound environment promotes faster healing than desiccation |
| Diabetes | Hyperglycemia impairs neutrophil, macrophage, and fibroblast function |
| Biofilm | Present in 60-90% of chronic wounds; requires debridement |
Cross-References
- Volume 03, Chapter 5: Skin Aging - Impaired healing in elderly
- Volume 05: Immunology - Inflammatory mediators
- Volume 33: Therapeutics - Wound care products
- Volume 35: Wound Healing - Clinical management
- Volume 36: Procedural Dermatology - Surgical wounds
References
- Gurtner GC, et al. Wound repair and regeneration. Nature 2008;453:314-321.
- Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014;6:265sr6.
- Sindrilaru A, Scharffetter-Kochanek K. Disclosure of the culprits: macrophages—versatile regulators of wound healing. Adv Wound Care 2013;2:357-368.
- Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
- Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004;9:283-289.
How to Cite
Cutisight. "Phases Overview." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-03-skin-reactions-and-interactions/03-wound-healing-biology/01-healing-phases/01-phases-overview
This is an open-access resource. Please cite appropriately when using in academic or clinical work.